A unique effort to discover new treatments for cancer, the Experimental Therapeutic Unit-IFOM leverages the strong biology and clinical relevance of the whole Campus IFOM and IEO’s research in cancer with industry-competitive drug discovery experience.
This drug discovery unit includes about 30 scientists (lead by Dr Mario Varasi):
The Experimental Therapeutics Unit-IFOM benefits from the TTFactor Advisory Board encompassing international scientific and business experience and it is working in close contact with the biologists at the IFOM-IEO Campus to select promising targets and help them in identifying small molecules to be developed up to an IND with the support of industrial partnerships.
A biology inspired-chemistry driven effort to identify small molecules for innovative therapy against cancer
An interview with the Managing Director of TTFactor
Via Adamello, 16 20139 MilanoT: +39 02 94375140 F +39 02 94375991e-mail:
TTFactor S.r.l.Sede legale: Via Ripamonti 435 MilanoSede Operativa Via Adamello 16 MilanoP.IVA/C.F. 07063660968